Determining the Immune Environment of Cutaneous T-cell Lymphoma Lesions Through the Assessment of Lesional Blood Drops

Overview

Journal Sci Rep

Specialty Science

Date 2021 Oct 5

PMID 34608214

Citations 1

Authors

Kan Torii

Yukinori Okada

Akimichi Morita

Affiliations

Soon will be listed here.

Abstract

Detailed analysis of the cells that infiltrate lesional skin cannot be performed in skin biopsy specimens using immunohistochemistry or cell separation techniques because enzyme treatments applied during the isolation step can destroy small amounts of protein and minor cell populations in the biopsy specimen. Here, we describe a method for isolating T cells from drops of whole blood obtained from lesions during skin biopsy in patients with cutaneous T-cell lymphoma. Lesional blood is assumed to contain lesional resident cells, cells from capillary vessels, and blood overflowing from capillary vessels into the lesion area. The lesional blood showed substantial increases in distinct cell populations, chemokines, and the expression of various genes. The proportion of CD8CD45RO T cells in the lesional blood negatively correlated with the modified severity-weighted assessment tool scores. CD4CD45RO T cells in the lesional blood expressed genes associated with the development of cancer and progression of cutaneous T-cell lymphoma. In addition, CD8CD45RO T cells in lesional blood had unique T-cell receptor repertoires in lesions of each stage. Assessment of lesional blood drops might provide new insight into the pathogenesis of mycosis fungoides and facilitate evaluation of the treatment efficacy for mycosis fungoides as well as other skin inflammatory diseases.

Citing Articles

A case of mycosis fungoides effectively treated with ultraviolet light A 1-light-emitting diode phototherapy.

Ikumi K, Torii K, Kio T, Masuda H, Kanayama Y, Morita A Photodermatol Photoimmunol Photomed. 2022; 39(1):69-71.

PMID: 35527358 PMC: 10084221. DOI: 10.1111/phpp.12798.

References

Henao-Mejia J, Elinav E, Strowig T, Flavell R . Inflammasomes: far beyond inflammation. Nat Immunol. 2012; 13(4):321-4. DOI: 10.1038/ni.2257. View

Gaydosik A, Tabib T, Geskin L, Bayan C, Conway J, Lafyatis R . Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell Lymphoma Skin Tumors. Clin Cancer Res. 2019; 25(14):4443-4454. PMC: 6635080. DOI: 10.1158/1078-0432.CCR-19-0148. View

Hoppe R, Medeiros L, Warnke R, Wood G . CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides. J Am Acad Dermatol. 1995; 32(3):448-53. DOI: 10.1016/0190-9622(95)90067-5. View

Kamstrup M, Gjerdrum L, Biskup E, Lauenborg B, Ralfkiaer E, Woetmann A . Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma. Blood. 2010; 116(14):2504-12. DOI: 10.1182/blood-2009-12-260216. View

Wu X, Lonsdorf A, Hwang S . Cutaneous T-cell lymphoma: roles for chemokines and chemokine receptors. J Invest Dermatol. 2009; 129(5):1115-9. PMC: 2669838. DOI: 10.1038/jid.2009.45. View

Hashizume H, Hansen A, Poulsen L, Thomsen A, Takigawa M, Thestrup-Pedersen K . In vitro propagation and dynamics of T cells from skin biopsies by methods using interleukins-2 and -4 or anti-CD3/CD28 antibody-coated microbeads. Acta Derm Venereol. 2010; 90(5):468-73. DOI: 10.2340/00015555-0927. View

Bankovic J, Stojsic J, Jovanovic D, Andjelkovic T, Milinkovic V, Ruzdijic S . Identification of genes associated with non-small-cell lung cancer promotion and progression. Lung Cancer. 2009; 67(2):151-9. DOI: 10.1016/j.lungcan.2009.04.010. View

Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D . Circos: an information aesthetic for comparative genomics. Genome Res. 2009; 19(9):1639-45. PMC: 2752132. DOI: 10.1101/gr.092759.109. View

Querfeld C, Leung S, Myskowski P, Curran S, Goldman D, Heller G . Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile. Cancer Immunol Res. 2018; 6(8):900-909. PMC: 6074045. DOI: 10.1158/2326-6066.CIR-17-0270. View

10.

Laharanne E, Oumouhou N, Bonnet F, Carlotti M, Gentil C, Chevret E . Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes. J Invest Dermatol. 2010; 130(6):1707-18. DOI: 10.1038/jid.2010.8. View

11.

Gallardo F, Sandoval J, Diaz-Lagares A, Garcia R, DAltri T, Gonzalez J . Notch1 Pathway Activation Results from the Epigenetic Abrogation of Notch-Related MicroRNAs in Mycosis Fungoides. J Invest Dermatol. 2015; 135(12):3144-3152. DOI: 10.1038/jid.2015.328. View

12.

McGirt L, Jia P, Baerenwald D, Duszynski R, Dahlman K, Zic J . Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides. Blood. 2015; 126(4):508-19. PMC: 4513251. DOI: 10.1182/blood-2014-11-611194. View

13.

Pletscher-Frankild S, Palleja A, Tsafou K, Binder J, Jensen L . DISEASES: text mining and data integration of disease-gene associations. Methods. 2014; 74:83-9. DOI: 10.1016/j.ymeth.2014.11.020. View

14.

Nairismagi M, Tan J, Lim J, Nagarajan S, Ng C, Rajasegaran V . JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma. Leukemia. 2016; 30(6):1311-9. PMC: 4895162. DOI: 10.1038/leu.2016.13. View

15.

Luo F, Zhao Y, Liu J . Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer. Int J Biochem Cell Biol. 2020; 123:105750. DOI: 10.1016/j.biocel.2020.105750. View

16.

Murray D, McMurray J, Eldershaw S, Pearce H, Davies N, Scarisbrick J . Progression of mycosis fungoides occurs through divergence of tumor immunophenotype by differential expression of HLA-DR. Blood Adv. 2019; 3(4):519-530. PMC: 6391678. DOI: 10.1182/bloodadvances.2018025114. View

17.

Kallies A, Zehn D, Utzschneider D . Precursor exhausted T cells: key to successful immunotherapy?. Nat Rev Immunol. 2019; 20(2):128-136. DOI: 10.1038/s41577-019-0223-7. View

18.

Abel E, Wood G, Hoppe R . Mycosis fungoides: clinical and histologic features, staging, evaluation, and approach to treatment. CA Cancer J Clin. 1993; 43(2):93-115. DOI: 10.3322/canjclin.43.2.93. View

19.

Abeni D, Frontani M, Sampogna F, Sera F, Bolli S, Corona R . Circulating CD8+ lymphocytes, white blood cells, and survival in patients with mycosis fungoides. Br J Dermatol. 2005; 153(2):324-30. DOI: 10.1111/j.1365-2133.2005.06755.x. View

20.

Kash N, Massone C, Fink-Puches R, Cerroni L . Phenotypic Variation in Different Lesions of Mycosis Fungoides Biopsied Within a Short Period of Time From the Same Patient. Am J Dermatopathol. 2016; 38(7):541-5. DOI: 10.1097/DAD.0000000000000493. View